Natural Autoantibody Application in IVIg

As a fundamental part of the immune system, natural autoantibodies (NAA) have a wide range of clinical applications including intravenous immunoglobulin. Creative Biolabs is committing to the researches of natural autoantibodies and related diseases based on our abundant experience, advanced technology platform, and professional teams. Our objective is to provide the best and most professional solutions and services available to our customers throughout the world.

Background NAA & IVIg FAQs Our ServiceResources & Products

Background

What Is Intravenous Immunoglobulin?

Intravenous immunoglobulin (IVIg) is a product made up of immunoglobulin or antibodies that can be given intravenously through a vein. It is one of the immunoglobulin therapies that use a mixture of normal human antibodies to treat a number of related diseases, particular immunologic deficiency. IVIg can be liquid or lyophilized powder containing human G isotype immunoglobulins (Ig) which is usually prepared from the human healthy blood.

Schematic representation of proposed mechanisms of action of IVIg in autoimmune and inflammatory diseases. Fig.1 Schematic representation of proposed mechanisms of action of IVIg in autoimmune and inflammatory diseases. (Negi, 2007)

NAA & IVIg

NAA and Intravenous Immunoglobulin

Natural autoantibodies are a type of antibodies produced by the human immune system, which suggests that NAA are a composition of human antibodies also IVIg. At the same time, IVIg has been applied to the treatment with a variety of NAA-related diseases especially autoimmune and systemic inflammatory conditions. Increasing researches indicated that IVIg could selectively and significantly reduce levels of abnormal antibodies without decreasing the levels of normal antibodies in some diseases. It was considered that IVIg can reverse abnormal NAA by increasing the catabolism of all serum IgG antibodies which finally replaced the abnormal NAA.

Scientific research and clinical usage show that IVIg is the first treatment achieving the perfect therapeutic effect in NAA-related diseases through selectively decreasing the circulating pathogenic NAA without affecting the level of normal antibodies.

The impact of IVIG on the innate and adaptive immune compartments in the context of autoimmune and inflammatory diseases. Fig.2 The impact of IVIG on the innate and adaptive immune compartments in the context of autoimmune and inflammatory diseases. (Galeotti, 2017)

FAQs

Our Service

NAA-related Applications Studied by Creative Biolabs

NAA is acting more and more important role in the immune system, human diseases, and clinical therapies. With the development of modern biological technologies, NAA has been widely used for intravenous immunoglobulin, clinical diagnosis, vaccine development, tumor surveillance, and other applications. As a leader in the biology industry, Creative Biolabs has been committed to the natural autoantibodies and related applications for several years. We are capable to provide our customers with a full range of quality services based on our powerful platform.

If you are interested in the natural autoantibodies and related applications or you have any question, just feel free to contact us for more detailed information.

Resource

Reference

  1. Negi, V.S.; et al. Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action. Journal of Clinical Immunology. 2007, 27(3): 233-245.
  2. Galeotti, C.; et al. IVIG-mediated effector functions in autoimmune and inflammatory diseases. International Immunology. 2017, 29(11): 491-498.
For Research Use Only | Not For Clinical Use

Related Services:

Products:

Resource:

Applications:

Online Inquiry
Inquiry